Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Client: QUEST DIAGNOSTICS INCORPORATED · Firm: QUEST DIAGNOSTICS INCORPORATED
Support changes to Sec. 8122 of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act). Support CDC opioid guidelines. Support Diagnostic Access and Innovation Act (DAIA). Support S. 2465 Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
QUEST DIAGNOSTICS INCORPORATED via QUEST DIAGNOSTICS INCORPORATED
2019 · second_quarter · Q2
LDT reform pathway engagement. Support CDC appropriations for improved pediatric reference intervals and harmonizing the reporting of clinical laboratory test results.
Support changes to Promoting Access to Medicare Act. Support CMS guidance on MA plan organization determinations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
QUEST DIAGNOSTICS INCORPORATED via QUEST DIAGNOSTICS INCORPORATED
2019 · first_quarter · Q1
LDT reform pathway engagement. Support CDC appropriations for improved pediatric reference intervals and harmonizing the reporting of clinical laboratory test results.
Support changes to Promoting Access to Medicare Act. Support CMS guidance on MA plan organization determinations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS INCORPORATED via QUEST DIAGNOSTICS INCORPORATED
2018 · fourth_quarter · Q4
Support changes to Promoting Access to Medicare Act (PAMA).
Support changes to Sec. 8122 of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act). Support CDC opioid guidelines. Support Diagnostic Access and Innovation Act (DAIA). Support S. 2465 Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS INCORPORATED via QUEST DIAGNOSTICS INCORPORATED
2018 · third_quarter · Q3
Support CDC opioid guidelines Support Diagnostic Access and Innovation Act (DAIA)
Support changes to Promoting Access to Medicare Act (PAMA).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS INCORPORATED via QUEST DIAGNOSTICS INCORPORATED
2018 · second_quarter · Q2
Support CDC opioid guidelines Support Diagnostic Access and Innovation Act (DAIA)
Support Promoting Access to Medicare Act (PAMA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE